EUVIMEDEUVIMED entdecken
Crossref

Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel‐Mediated Reprogramming of Cancer‐Associated Fibroblasts in Osteosarcoma

Hui Wang, Yu Chen, Ran Wei, Jinlong Zhang, Jiahui Zhu, Wenbin Wang, Zhenfei Wang, Zulpikar Wupur, Yujing Li iD, Huan Meng iD

Advanced Materials · 2024-04 · 36 (15)

DOI: 10.1002/adma.202309591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 29.12.2023. Verfasst von Hui Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Technology, Beijing Institute of Technology, Beijing, 100081, China. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Institute of Technology Research Fund Program for Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In osteosarcoma, immunotherapy often faces hurdles posed by cancer‐associated fibroblasts (CAFs) that secrete dense extracellular matrix components and cytokines. Directly removing CAFs may prove ineffective and even promote tumor metastasis. To address this challenge, a sequential nanocomposite hydrogel that reshapes CAF behavior is developed, enhancing tumor‐infiltrating T‐cells in osteosarcoma. The approach utilizes an injectable blend of carboxymethyl chitosan and tetrabasic polyethylene glycol, forming a hydrogel for controlled release of a potent CAF suppressor (Nox4 inhibitor, Nox4 i ) and liposomal Doxorubicin (L‐Dox) to induce immunogenic cell death (ICD) upon in situ administration. Nox4 i effectively counters CAF activation, overcoming T‐cell exclusion mechanisms, followed by programmed L‐Dox release for ICD induction in stroma‐rich osteosarcoma models. Combining the co‐delivery gel with αPD‐1 checkpoint inhibitor further enhances its effectiveness in an orthotopic osteosarcoma model. Immunophenotyping data underscore a significant boost in tumor T‐cell infiltration and favorable anti‐tumor immunity at the whole‐animal level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer-Associated FibroblastsOsteosarcomaBone NeoplasmsAnimalsNanogelsDoxorubicinHydrogelsImmunotherapyCell Line, TumorTumor MicroenvironmentPolyethylene Glycols

Stichwörter der Autor:innen

Nox4 inhibitioncancer‐associated fibroblastschemoimmunotherapyosteosarcomasequential nanocomposite hydrogels

Substanzen

Nanogelsliposomal doxorubicinDoxorubicinHydrogelsPolyethylene Glycols

Autor:innen und Institutionen

  • School of Medical Technology, Beijing Institute of Technology, Beijing, 100081, China.
  • CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.
  • School of Materials Science and Engineering, Beijing Institute of Technology, Beijing, 100081, China.
  • Musculoskeletal Tumor Center, Beijing Key Laboratory of Musculoskeletal Tumor, Peking University People's Hospital, Beijing, 100044, China.
  • Qiushi College, Beijing Institute of Technology, Beijing, 100081, China.

ORCID-Profile: Yujing Li, Huan Meng

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Beijing Institute of Technology Research Fund Program for Young Scholars
  • Peking University People's Hospital Scientific Research Development Funds
  • The CAS Project for Young Scientists in Basic Research

Zitieren

APA

Wang, H., Chen, Y., Wei, R., Zhang, J., Zhu, J., Wang, W., Wang, Z., Wupur, Z., Li, Y., & Meng, H. (2024). Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel‐Mediated Reprogramming of Cancer‐Associated Fibroblasts in Osteosarcoma. Advanced Materials, 36(15). https://doi.org/10.1002/adma.202309591

Vancouver

Wang H, Chen Y, Wei R, Zhang J, Zhu J, Wang W, et al. Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel‐Mediated Reprogramming of Cancer‐Associated Fibroblasts in Osteosarcoma. Advanced Materials. 2024;36(15). doi:10.1002/adma.202309591

BibTeX
@article{Wang2024,
  author = {Wang, Hui and Chen, Yu and Wei, Ran and Zhang, Jinlong and Zhu, Jiahui and Wang, Wenbin and Wang, Zhenfei and Wupur, Zulpikar and Li, Yujing and Meng, Huan},
  title = {Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel‐Mediated Reprogramming of Cancer‐Associated Fibroblasts in Osteosarcoma},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {15},
  doi = {10.1002/adma.202309591}
}
Kostenlos starten →